- Home
- OCGN vs ARAY Comparison
OCGN vs ARAY Comparison
Compare OCGN & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- ARAY
- Stock Information
- Founded
- OCGN 2013
- ARAY 1990
- Country
- OCGN United States
- ARAY United States
- Employees
- OCGN N/A
- ARAY N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- ARAY Medical/Dental Instruments
- Sector
- OCGN Health Care
- ARAY Health Care
- Exchange
- OCGN Nasdaq
- ARAY Nasdaq
- Market Cap
- OCGN 229.2M
- ARAY 229.3M
- IPO Year
- OCGN N/A
- ARAY 2007
- Fundamental
- Price
- OCGN $0.68
- ARAY $2.11
- Analyst Decision
- OCGN Strong Buy
- ARAY Strong Buy
- Analyst Count
- OCGN 3
- ARAY 1
- Target Price
- OCGN $6.00
- ARAY $9.00
- AVG Volume (30 Days)
- OCGN 3.5M
- ARAY 883.1K
- Earning Date
- OCGN 03-05-2025
- ARAY 02-05-2025
- Dividend Yield
- OCGN N/A
- ARAY N/A
- EPS Growth
- OCGN N/A
- ARAY N/A
- EPS
- OCGN N/A
- ARAY N/A
- Revenue
- OCGN $4,700,000.00
- ARAY $453,140,000.00
- Revenue This Year
- OCGN N/A
- ARAY $6.97
- Revenue Next Year
- OCGN N/A
- ARAY $5.02
- P/E Ratio
- OCGN N/A
- ARAY N/A
- Revenue Growth
- OCGN N/A
- ARAY 1.26
- 52 Week Low
- OCGN $0.64
- ARAY $1.40
- 52 Week High
- OCGN $2.11
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- OCGN 40.75
- ARAY 43.05
- Support Level
- OCGN $0.67
- ARAY $2.15
- Resistance Level
- OCGN $0.76
- ARAY $2.32
- Average True Range (ATR)
- OCGN 0.04
- ARAY 0.16
- MACD
- OCGN 0.00
- ARAY -0.04
- Stochastic Oscillator
- OCGN 28.57
- ARAY 4.55
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.